Lithuania vs East Timor: Access to anti-retroviral drugs, female (%)
Lithuania
56.0%
in 2024
East Timor
57.0%
in 2024
Lithuania rank
110th
East Timor rank
108th
Access to anti-retroviral drugs, female (%) over time
- Lithuania
- East Timor
How they compare
East Timor currently reports 57.0% against 56.0% in Lithuania, a difference of 1.0%.
The two have swapped places 6 times across 23 shared years of data; in 2000 it was East Timor ahead.
Lithuania ranks 110th and East Timor ranks 108th of 141 countries.
Across the 3 decades both report, Lithuania averaged higher in 1 and East Timor in 2.
Head to head by decade
| Decade | Lithuania | East Timor | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 1.6% | 0.4% | Lithuania |
| 2010s | 20.7% | 22.1% | 1.4% | East Timor |
| 2020s | 45.8% | 49.0% | 3.2% | East Timor |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Lithuania or East Timor?
- East Timor, at 57.0% against 56.0% in Lithuania as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Lithuania and East Timor?
- 1.0%, with East Timor ahead.
- How many years of comparable data are there for Lithuania and East Timor?
- 23 years are reported by both, from 2000 to 2024.
- How do Lithuania and East Timor rank globally for access to anti-retroviral drugs, female?
- Lithuania ranks 110th and East Timor ranks 108th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.